59MO COTESARC – A multicentre, phase I-II clinical trial evaluating the combination of MEK and PDL-1 inhibitors in patients (pts) with advanced soft tissue sarcoma (STS): Results from complex (CG) and simple genomic (SG) STS cohorts
| Autor: | Dufresne, A., Brahmi, M., Cropet, C., Bahleda, R., Watson, S., Pautier, P., Ray-Coquard, I.L., Aerts, I., Duffaud, F., Defachelles, A-S., Verret, B., Garin, G. Fournier, Guichard, C., Bernardin, M., Perol, D., Blay, J-Y., Corradini, N. |
|---|---|
| Zdroj: | In ESMO Open March 2024 9 Supplement 2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|